LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

Chia‐Chen Liu(WinnMed), Guojun Bu(Hong Kong University of Science and Technology), David Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), Julie L. Prior(Imaging Center)
Proceedings of the National Academy of Sciences
March 1, 2010
Cited by 202


Related Papers